Wave Life Sciences Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Wave Life Sciences Ltd. generated cash of -$19,431,000, which is more than the previous year. Cash used in financing activities reached the amount of $132,534,000 last year. Net change in cash is therefore $111,893,000.
Cash Flow
| 2014 | -4.42M | -257K | 5.61M |
|---|---|---|---|
| 2015 | -12.52M | -2.90M | 175.59M |
| 2016 | -31.87M | -8.16M | 29.12M |
| 2017 | -83.67M | -18.89M | 94.37M |
| 2018 | -22.86M | -9.93M | 65.09M |
| 2019 | -188.23M | -3.91M | 164.39M |
| 2020 | -115.98M | -1.33M | 154.53M |
| 2021 | -88.99M | -560K | 55.82M |
| 2022 | -127.78M | -1.25M | 67.18M |
| 2023 | -19.43M | -1.11M | 132.53M |
WVE Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 92.15M | 154.21M | 188.14M | 150.80M | 178.44M | 146.11M | 150.29M | 161.22M | 1.04M | 439K |
Operating activities | ||||||||||
Net income | -57.51M | -161.82M | -122.24M | -149.91M | -193.63M | -146.65M | -102.03M | -55.40M | -19.2M | -5.22M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 9.20M | 10.11M | 9.83M | 9.98M | 9.20M | 5.58M | 2.15M | 784K | 594K | 281K |
Stock-based compensation expense | 9.79M | 17.19M | 16.40M | 14.29M | 19.50M | 0 | 12.14M | 6.84M | 4.02M | 0 |
| Deferred income tax benefit | 9.79M | 17.19M | 16.40M | 14.29M | 19.50M | 0 | 12.14M | 6.84M | 4.02M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -21.08M | 0 | 30M | 20M | 10M | -59M | -1M | 0 | 193K | -129K |
Inventories | 0 | 0 | 2.04M | 4.60M | -5.45M | -4.08M | 0 | 0 | 242K | 398K |
Accounts payable | -3.76M | 9.34M | -6.56M | 5.11M | -3.49M | 4.93M | 3.89M | 3.36M | 1.64M | 9K |
Cash generated by operating activities | -19.43M | -127.78M | -88.99M | -115.98M | -188.23M | -22.86M | -83.67M | -31.87M | -12.52M | -4.42M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -75.04M | 0 | 0 | 0 | 0 | 0 | -2.59M | -1.05M | 0 |
Investments In Property Plant And Equipment | -1.11M | -1.36M | -560K | -1.33M | -3.91M | -9.93M | -18.88M | -5.56M | -1.85M | -590K |
Acquisitions Net | 0 | 106K | 0 | 0 | 0 | 0 | 0 | 4K | 3K | 0 |
Cash generated by investing activities | -1.11M | -1.25M | -560K | -1.33M | -3.91M | -9.93M | -18.89M | -8.16M | -2.90M | -257K |
Financing activities | ||||||||||
Common Stock Issued | 131.27M | 52.32M | 54.97M | 154.36M | 161.79M | 60M | 93.50M | 0 | 113.07M | 5.58M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 65.11M | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -16K | -62K | -62K | -126K | 0 |
Cash used in financing activities | 132.53M | 67.18M | 55.82M | 154.53M | 164.39M | 65.09M | 94.37M | 29.12M | 175.59M | 5.61M |
Net Change In Cash | 111.89M | -62.05M | -33.93M | 37.34M | -27.63M | 32.33M | -7.79M | -10.92M | 160.17M | 609K |
Cash at end of period | 204.05M | 92.15M | 154.21M | 188.14M | 150.80M | 178.44M | 142.50M | 150.29M | 161.22M | 1.04M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |